Department of Pediatric Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.
Eur J Cardiothorac Surg. 2012 Aug;42(2):226-32; discussion 232. doi: 10.1093/ejcts/ezs013. Epub 2012 Mar 7.
Small pulmonary allografts are difficult to obtain, thus we now use a tailor-made right ventricle to pulmonary artery (RV-PA) conduit for the Ross procedure, consisting of a fresh non-treated autologous pericardial (AP) patch for the posterior wall and expanded polytetrafluoroethylene (ePTFE) monocusp patch for the anterior wall. Long-term durability and RV function were assessed.
Between 1997 and 2011, tailor-made conduits were used for right ventricular outflow tract (RVOT) reconstruction in 38 consecutive Ross procedures. Patients were divided into two groups by type of material used for reconstruction of the RVOT anterior wall: Group A (n = 11), pedicled AP patch with ePTFE monocusp valve; Group B (n = 27), ePTFE patch with the ePTFE monocusp valve. The posterior wall was reconstructed with an AP patch in both. We examined survival and freedom from re-intervention, haemodynamic indices by cardiac catheterization, efficacy of the RVOT by ultrasound cardiography (UCG) and exercise capacity at 3 years after the operation. The mean follow-up period was 6.0 ± 0.5 years.
No patients required re-intervention for neo-aortic valve. Overall survival and freedom from re-intervention for RVOT reconstruction at 10 years were 100 and 100%, respectively, in Group A, and 92.6 and 89.4%, respectively, in Group B. No patients showed an RVOT pressure gradient greater than 25 mmHg by cardiac catheterization at 1 year after the operation. All showed less than 2.5 m/s of RVOT flow estimated by Doppler UCG at 6 years. RV function in both groups was preserved at normal in spite of a higher incidence of free RVOT insufficiency in Group A (P = 0.018). Exercise capacity was also preserved at normal in both groups.
In paediatric patients undergoing the Ross procedure, a tailor-made conduit might be helpful to avoid growth-related RVOT obstruction. The incidence of free RVOT insufficiency was lower than with an anterior ePTFE patch, thus our method may be a better option to preserve RV function for a longer period.
小的同种异体肺移植很难获得,因此我们现在使用定制的右心室到肺动脉(RV-PA)导管进行 Ross 手术,由新鲜未经处理的自体心包(AP)补片制成后壁和扩展聚四氟乙烯(ePTFE)单瓣补片制成前壁。评估长期耐久性和 RV 功能。
1997 年至 2011 年,在 38 例连续 Ross 手术中使用定制导管进行右心室流出道(RVOT)重建。根据用于重建 RVOT 前壁的材料类型,患者分为两组:A 组(n=11),带 ePTFE 单瓣阀的带蒂 AP 补片;B 组(n=27),带 ePTFE 单瓣阀的 ePTFE 补片。后壁均用 AP 补片重建。我们检查了术后 3 年的生存和免于再干预、心导管检查的血液动力学指标、超声心动图(UCG)评估的 RVOT 效果和运动能力。平均随访时间为 6.0±0.5 年。
无患者因新主动脉瓣需要再次干预。A 组 10 年时总体生存率和 RVOT 重建免于再干预率分别为 100%和 100%,B 组分别为 92.6%和 89.4%。术后 1 年心导管检查时无患者出现 RVOT 压力梯度大于 25mmHg。6 年时,所有患者的 RVOT 流速均小于多普勒 UCG 估计的 2.5m/s。两组 RV 功能均保持正常,尽管 A 组游离 RVOT 不足的发生率较高(P=0.018)。两组运动能力也保持正常。
在接受 Ross 手术的儿科患者中,定制的导管可能有助于避免与生长相关的 RVOT 阻塞。游离 RVOT 不足的发生率低于前壁 ePTFE 补片,因此我们的方法可能是更长时间保留 RV 功能的更好选择。